FAKTOR OPTIONSSCHEIN - STRYKER CORP. Share Price

Certificat

DE000GQ2W096

Market Closed - Bid/Ask 11:57:04 21/06/2024 pm IST After market 01:28:24 am
2.35 EUR -7.84% Intraday chart for FAKTOR OPTIONSSCHEIN - STRYKER CORP. 2.58 +9.79%
Current month-4.14%
1 month+23.19%
Date Price Change
21/24/21 2.35 -7.84%
20/24/20 2.55 -32.72%
19/24/19 3.79 +11.80%
18/24/18 3.39 +12.25%
17/24/17 3.02 +5.96%

Real-time BOERSE MUENCHEN

Last update June 21, 2024 at 11:57 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Goldman Sachs
WKN GQ2W09
ISINDE000GQ2W096
Date issued 23/08/2023
Strike 318.6 $
Maturity Unlimited
Parity 8.98 : 1
Emission price 8.47
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 24.25
Lowest since issue 0.74
Spread 0.1
Spread %3.80%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
341.4 USD
Average target price
372.9 USD
Spread / Average Target
+9.25%
Consensus